In the hypothalamus, insulin takes on many roles involved in energy homoeostasis. Therefore, the aim of this study was to examine hypothalamic insulin expression during the initial phase of the metabolic response to fasting. Hypothalamic insulin content was assessed by both radioimmunoassay and Western blot. The relative expression of insulin mRNA was examined by qPCR. Immunofluorescence and immunohistochemistry were used to determine the distribution of insulin immunopositivity in the hypothalamus. After 6-h fasting, both glucose and insulin levels were decreased in serum but not in the cerebrospinal fluid. Our study showed for the first time that, while the concentration of circulating glucose and insulin decreased, both insulin mRNA expression and insulin content in the hypothalamic parenchyma were increased after short-term fasting. Increased insulin immunopositivity was detected specifically in the neurons of the hypothalamic periventricular nucleus and in the ependymal cells of fasting animals. These novel findings point to the complexity of mechanisms regulating insulin expression in the CNS in general and in the hypothalamus in particular.
Striving for longevity is neither a recent human desire nor a novel scientific field. The first article on this topic was published in 1838, when the average human life expectancy was approximately 40 years. Although nowadays people on average live almost as twice as long, we still (and perhaps more than ever) look for new ways to extend our lifespan. During this seemingly endless journey of discovering efficient methods to prolong life, humans were enthusiastic regarding several approaches, one of which is caloric restriction (CR). Where does CR, initially considered universally beneficial for extending both lifespan and health span, stand today? Does a lifelong decrease in food consumption represent one of the secrets of centenarians’ long and healthy life? Do we still believe that if we eat less, we will live longer? This review aims to summarize the current literature on CR as a potential life-prolonging intervention in humans and discusses metabolic pathways that underlie this effect.
BackgroundPrenatal stress may increase risk of developing cardiovascular disorders in
adulthood. The cardiotoxic effects of catecholamines are mediated via
prolonged adrenergic receptor stimulation and increased oxidative stress
upon their degradation by monoamine oxidase A (MAO-A).ObjectivesWe investigated long-term effects of prenatal stress on β (1, 2, 3)
adrenergic receptors and MAO-A gene expression in the hearts of adult rat
offspring.MethodsPregnant rats were exposed to unpredictable mild stress during the third week
of gestation. RNA was isolated from left ventricular apex and base of adult
offspring. Quantitative PCR was used to measure gene expression in collected
ventricular tissue samples. The level of significance was set to p <
0.05.Resultsβ3 adrenergic receptor mRNA was undetectable in rat left ventricle.
β1 adrenergic receptor was the predominantly expressed subtype at the
apical and basal left ventricular myocardium in the control females. Male
offspring from unstressed mothers displayed higher apical cardiac β1
than β2 adrenergic receptor mRNA levels. However, β1 and
β2 adrenergic receptor mRNAs were similarly expressed at the
ventricular basal myocardium in males. Unlike males, prenatally stressed
females exhibited decreased β1 adrenergic receptor mRNA expression at
the apical myocardium. Prenatal stress did not affect cardiac MAO-A gene
expression.ConclusionsCollectively, our results show that prenatal stress may have exerted region-
and sex-specific β1 and β2 adrenergic receptor expression
patterns within the left ventricle.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.